Cargando…
Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World
The U.S. must assess its pricing and reimbursement system for prescription drugs. The current system is attracting intense scrutiny for various reasons. Drug pricing and reimbursement mechanisms used in other countries are described to assess what an optimal system should entail.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978557/ https://www.ncbi.nlm.nih.gov/pubmed/27384235 http://dx.doi.org/10.1634/theoncologist.2016-0106 |
_version_ | 1782447192339906560 |
---|---|
author | Goldstein, Daniel A. Sarfaty, Michal |
author_facet | Goldstein, Daniel A. Sarfaty, Michal |
author_sort | Goldstein, Daniel A. |
collection | PubMed |
description | The U.S. must assess its pricing and reimbursement system for prescription drugs. The current system is attracting intense scrutiny for various reasons. Drug pricing and reimbursement mechanisms used in other countries are described to assess what an optimal system should entail. |
format | Online Article Text |
id | pubmed-4978557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AlphaMed Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-49785572016-08-25 Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World Goldstein, Daniel A. Sarfaty, Michal Oncologist Value in Cancer Care The U.S. must assess its pricing and reimbursement system for prescription drugs. The current system is attracting intense scrutiny for various reasons. Drug pricing and reimbursement mechanisms used in other countries are described to assess what an optimal system should entail. AlphaMed Press 2016-08 2016-07-06 /pmc/articles/PMC4978557/ /pubmed/27384235 http://dx.doi.org/10.1634/theoncologist.2016-0106 Text en ©AlphaMed Press |
spellingShingle | Value in Cancer Care Goldstein, Daniel A. Sarfaty, Michal Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World |
title | Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World |
title_full | Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World |
title_fullStr | Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World |
title_full_unstemmed | Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World |
title_short | Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World |
title_sort | cancer drug pricing and reimbursement: lessons for the united states from around the world |
topic | Value in Cancer Care |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978557/ https://www.ncbi.nlm.nih.gov/pubmed/27384235 http://dx.doi.org/10.1634/theoncologist.2016-0106 |
work_keys_str_mv | AT goldsteindaniela cancerdrugpricingandreimbursementlessonsfortheunitedstatesfromaroundtheworld AT sarfatymichal cancerdrugpricingandreimbursementlessonsfortheunitedstatesfromaroundtheworld |